![Christopher Meldrum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Meldrum
Vorstandsvorsitzender bei
Avicenna Biosciences, Inc.
Profil
Christopher S.
Meldrum was the founder of Exigent Pharmaceuticals, Inc., founded in 2007, where the title held was Acting President.
The current job is President, Chief Executive Officer & Director at Avicenna Biosciences, Inc. Former jobs include President, Chief Executive Officer & Director at Pique Therapeutics, Inc.; President & Chief Executive Officer at Arcato Laboratories, Inc.; Chairman at Kylin Therapeutics, Inc.; Director at Cogenics Icoria, Inc.; Managing Director at Golden Pine Ventures LLC from 2004 to 2019; Secretary & Director at Catena Pharmaceuticals, Inc. from 2012 to 2013; and Principal at Purdue University and the University of Minnesota.
Education includes an undergraduate degree from the University of Utah and an MBA from the University of Minnesota.
Aktive Positionen von Christopher Meldrum
| Unternehmen | Position | Beginn |
|---|---|---|
Avicenna Biosciences, Inc.
 Avicenna Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that intends to redesign and optimize drug candidates | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Christopher Meldrum
| Unternehmen | Position | Ende |
|---|---|---|
Golden Pine Ventures LLC
 Golden Pine Ventures LLC Investment ManagersFinance Golden Pine Ventures LLC invests in companies located in the US. They target companies operating in the fields of biotechnology and biomedical opportunities which have the potential to yield a substantial return within a 3 to 5-year period. They provide financing for seed and early stage capital requirements. The firm seeks an equal equity ownership position in these new companies. | Private Equity Investor | 01.07.2019 |
Catena Pharmaceuticals, Inc.
 Catena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer drugs | Direktor/Vorstandsmitglied | 09.07.2013 |
Kylin Therapeutics, Inc.
 Kylin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Vorsitzender | 01.07.2013 |
Arcato Laboratories, Inc.
 Arcato Laboratories, Inc. Medical SpecialtiesHealth Technology Develops, produces and commercializes oral healthcare products | Vorstandsvorsitzender | - |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Christopher Meldrum
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
4
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Cogenics Icoria, Inc.
 Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Kylin Therapeutics, Inc.
Kylin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology services | Commercial Services |
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Golden Pine Ventures LLC
Golden Pine Ventures LLC Investment ManagersFinance Golden Pine Ventures LLC invests in companies located in the US. They target companies operating in the fields of biotechnology and biomedical opportunities which have the potential to yield a substantial return within a 3 to 5-year period. They provide financing for seed and early stage capital requirements. The firm seeks an equal equity ownership position in these new companies. | Finance |
Catena Pharmaceuticals, Inc.
Catena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer drugs | Health Technology |
Exigent Pharmaceuticals, Inc.
 Exigent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceutical products | Health Technology |
Pique Therapeutics, Inc.
 Pique Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic vaccines for the treatment of cancer | Health Technology |
Arcato Laboratories, Inc.
Arcato Laboratories, Inc. Medical SpecialtiesHealth Technology Develops, produces and commercializes oral healthcare products | Health Technology |
Avicenna Biosciences, Inc.
Avicenna Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that intends to redesign and optimize drug candidates | Health Technology |
